THE ROLE OF ARTIFICIAL INTELLIGENCE IN PERSONALISED MEDICINE: ADVANCEMENTS, CHALLENGES, AND FUTURE PERSPECTIVES

Artificial Intelligence (AI) has emerged as a transformative technology in healthcare, significantly advancing personalised medicine. By leveraging vast amounts of data, AI enhances early disease detection, tailors treatments to individual patients, and optimises medical resource management. Despite these advantages, the integration of AI in healthcare presents challenges, including concerns over data privacy, acceptance among healthcare professionals, and the need for comprehensive regulatory frameworks. Therefore, this study investigates the impact of AI on personalised medicine, assessing its benefits, limitations, and real-world applications. It explores AI’s role in diagnostics, personalised treatment strategies, and the optimisation of medical workflows, while critically examining ethical and legal challenges. The study also underscores the necessity of robust regulations to ensure responsible and ethical AI deployment in healthcare. A systematic documentary analysis of scientific articles, case studies, and healthcare organisation reports forms the basis of this research. Case studies from hospitals and companies that have successfully implemented AI are analysed to evaluate its impact on diagnostic accuracy, treatment efficiency, and medical costs. The findings are correlated with existing literature to provide a comprehensive perspective on current and future trends in AI-driven personalised medicine. The results of this study show that AI has demonstrated significant improvements in diagnostic precision, reduced the time required for disease identification, and enhanced the effectiveness of personalised treatment plans. Studies indicate that AI-driven approaches contribute to cost reductions by minimising late-stage treatments and enabling more efficient allocation of medical resources. However, critical challenges such as algorithm transparency, bias mitigation, and patient data security continue to hinder widespread AI adoption in healthcare.

Authors

Publication Details

Journal
BUSINESS EXCELLENCE AND MANAGEMENT
Published
2025-02-28
DOI
https://doi.org/10.24818/beman/2025.15.1-05
Citations
1
Primary Topic
Biomedical and Engineering Education
Type
article
Field-Weighted Citation Impact
0.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE ROLE OF ARTIFICIAL INTELLIGENCE IN PERSONALISED MEDICINE: ADVANCEMENTS, CHALLENGES, AND FUTURE PERSPECTIVES

Ioana-Marcela PĂCURARU, Ciprian-Sorin CHIRVASE, Ştefan-Ioan TIRITEU
1 citations
BUSINESS EXCELLENCE AND MANAGEMENT
Biomedical and Engineering Education
0.67
article

THE ROLE OF ARTIFICIAL INTELLIGENCE IN PERSONALISED MEDICINE: ADVANCEMENTS, CHALLENGES, AND FUTURE PERSPECTIVES

Ioana-Marcela PĂCURARU, Ciprian-Sorin CHIRVASE, Ştefan-Ioan TIRITEU
article en
1 citations

Abstract

Artificial Intelligence (AI) has emerged as a transformative technology in healthcare, significantly advancing personalised medicine. By leveraging vast amounts of data, AI enhances early disease detection, tailors treatments to individual patients, and optimises medical resource management. Despite these advantages, the integration of AI in healthcare presents challenges, including concerns over data privacy, acceptance among healthcare professionals, and the need for comprehensive regulatory frameworks. Therefore, this study investigates the impact of AI on personalised medicine, assessing its benefits, limitations, and real-world applications. It explores AI’s role in diagnostics, personalised treatment strategies, and the optimisation of medical workflows, while critically examining ethical and legal challenges. The study also underscores the necessity of robust regulations to ensure responsible and ethical AI deployment in healthcare. A systematic documentary analysis of scientific articles, case studies, and healthcare organisation reports forms the basis of this research. Case studies from hospitals and companies that have successfully implemented AI are analysed to evaluate its impact on diagnostic accuracy, treatment efficiency, and medical costs. The findings are correlated with existing literature to provide a comprehensive perspective on current and future trends in AI-driven personalised medicine. The results of this study show that AI has demonstrated significant improvements in diagnostic precision, reduced the time required for disease identification, and enhanced the effectiveness of personalised treatment plans. Studies indicate that AI-driven approaches contribute to cost reductions by minimising late-stage treatments and enabling more efficient allocation of medical resources. However, critical challenges such as algorithm transparency, bias mitigation, and patient data security continue to hinder widespread AI adoption in healthcare.

BUSINESS EXCELLENCE AND MANAGEMENTVol. 15(1)
Openalex Percentile: Top 34%
Biomedical and Engineering Education
0.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.